The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina

Bosnia and Herzegovina: The number of people with susceptibility test result for rifampicin was 255 in 2021. ▼ Falling

Latest (2021)
255
Change on year
up 22.6%
World rank
89th
of 155 countries
All-time high
399
in 2018
All-time low
208
in 2020
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina, 2017–2021

01002003004002017201920212017: 3812018: 3992019: 3062020: 2082021: 255

Source: World Health Organization, Global Health Observatory.

Analysis

In 2021, the number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina stood at 255.

That represents a change of up 22.6% on the previous year and down 33.1% over five years.

That places Bosnia and Herzegovina 89th out of 155 countries with data for 2021, putting it in the middle of the range.

The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Bosnia and Herzegovina, 2017 to 2021.
Year Value Change
2017 381
2018 399 +4.7%
2019 306 -23.3%
2020 208 -32.0%
2021 255 +22.6%

Bosnia and Herzegovina compared with similar countries

  • Bosnia and Herzegovina's 255 is below the median for upper middle income countries, which is 880, 29% of the median. (46 countries reporting)
  • Bosnia and Herzegovina's 255 is above the median for Europe & Central Asia, which is 229.5, 1.1× the median. (44 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 362 306 399 3
2020s 231.5 208 255 2

Countries ranked near Bosnia and Herzegovina

  1. 86 Belgium 377 compare
  2. 87 El Salvador 316 compare
  3. 88 Netherlands 270 compare
  4. 90 Czechia 239 compare
  5. 91 Lebanon 228 compare
  6. 92 Switzerland 220 compare

See the full ranking of 157 places →

More health data for Bosnia and Herzegovina

All data for Bosnia and Herzegovina →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina?
The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina was 255 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Bosnia and Herzegovina?
The highest recorded value was 399 in 2018.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bosnia and Herzegovina?
The lowest recorded value was 208 in 2020.
How does Bosnia and Herzegovina rank for the number of people with susceptibility test result for rifampicin?
Bosnia and Herzegovina ranks 89th out of 155 countries with data for 2021.
Where does this Bosnia and Herzegovina data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/bosnia-and-herzegovina/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/bosnia-and-herzegovina/">The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed